Related Experiment Video
Updated: Jun 21, 2026
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
Protective effect of Terminalia chebula against lysosomal enzyme alterations in isoproterenol-induced cardiac damage
Subramaniyan Suchalatha1, Chennam Srinivasulu Shyamala Devi
1Department of Biochemistry, University of Madras, Guindy Campus, Chennai, India.
Background:
Terminalia chebula is an ayurvedic drug recommended for the treatment of heart diseases. Earlier studies by the authors validated the beneficial cardioprotective effect of T chebula against isoproterenol-induced myocardial infarction.
Objectives:
To evaluate the therapeutic efficacy of T chebula in protecting against isoproterenol-induced lysosomal membrane damage.
Methods:
Lysosomal enzyme activities from the serum, heart and lysosomal fractions were determined. The triphenyltetrazolium chloride assay was used to confirm the protective effect of T chebula on the myocardium.
Results:
Isoproterenol administration produced significant cardiac damage (as seen by the triphenyltetrazolium chloride assay) and significantly altered lysosomal enzyme activities. Pretreatment with an ethanol extract of T chebula was found to retain near normal activities of lysosomal enzymes in rats given T chebula or T chebula plus isoproterenol compared with rats given isoproterenol alone.
Conclusions:
Pretreatment with T chebula extract stabilizes the lysosomal membrane and, thus, may have prevented myocardial damage.
